Disease emergence in immunocompromised populations Jamie Lloyd-Smith Penn State University Africa: a changing immune landscape HIV prevalence in adult populations How might this influence disease emergence? Heterogeneous immunity and disease emergence In addition to HIV, many other factors affect the host immune response to a given pathogen: Host genetics Co-infections Immunosuppressive drugs Nutrition Age Vaccination and previous exposure Individual-level effects of compromised immunity can include: greater susceptibility to infection higher pathogen loads disseminated infection and death longer duration of infection What are the population-level effects of immunocompromised groups on pathogen emergence? Modelling pathogen emergence Building on work by Antia et al (2003), Andre & Day (2005), and Yates et al (2006). Emergence = introduction + adaptation + invasion A simple model for pathogen invasion Linearized birth-and-death process in continuous time. Stochastic model for disease invasion into a large population. Population is structured into groups according to immunocompetence. • Each group has characteristic susceptibility and infectiousness, which can vary independently or co-vary. Pathogen is structured into strains representing stages of adaptation to a novel host species. Emergence = introduction + adaptation + invasion A simple model for pathogen adaptation Between-host transmission bottleneck causes founder effect Model assumes: Occurs with fixed probability per transmission event. Within-host mutation arises during infection and goes to fixation within host Occurs at a constant rate within each infected host. a probability over an average duration of infection. Pathogen fitness landscapes adaptation One-step adaptation 1.5 R0 in healthy population 1 0.5 0 Initial strain Two-step adaptation Adapted strain adaptation R0 in healthy population 1.5 1 0.5 0 Initial strain Intermediate Adapted strain strain Model assumptions Invasion model (epidemiology) Susceptible pool is large compared to outbreak size. Per capita rates of recovery and transmission are constant. Type of index case is determined by group size weighted by susceptibility: Pr(index case in group i) = (Size of group i) × (Susc. of group i) . Sj (Size of group j) × (Susc. of group j) Adaptation model (evolution) Parameters describing relative susceptibility and infectiousness don’t depend on pathogen strain. Evolutionary and epidemiological parameters are independent of one another. Model equations: 1 group, 1 strain q Probabilit y that outbreak carried by a single case will go extinct. Transmission rate Recovery rate q q 2 1 q where, because of the large-population assumption: Pr 2 chains go extinct Pr 2 chains go extinct 2 q2 Model equations: 1 group, 2 strains q ( i ) Probabilit y that outbreak of strain i carried by a single case will go extinct. ( i ) Transmission rate for strain i ( i ) Recovery rate for strain i Rate of within - host evolution u Probabilit y of between - host transmission q (1) 1 u (1) q u q q q 1 q (1) 2 (1) (1) q ( 2) ( 2) q ( 2) 2 (1) ( 2 ) (1) (1) ( 2) 1 ( 2) ( 2) q ( 2) ( 2) (1) Model equations: 2 groups, 2 strains q (j i ) Probabilit y that outbreak of strain i carried by a single case in group j will go extinct. (jki ) Transmission rate from group j to group k for strain i (j i ) Recovery rate for case of strain i in group j within - host evolution rate; q1(1) 1 u (1) 11 (1) 2 q1 u prob. of between - host evolution q q q q q 12(1) q1(1) q2(1) u 11(1) q1(1) q1( 2 ) 12(1) q1(1) q2( 2 ) 1 u q q q u q q q 1 q q q 1 q q q 1 q1( 2 ) 1(1) 1 11(1) 12(1) 1(1) q2(1) (1) 21 (1) (1) 1 2 (1) 22 ( 2) 2 q1( 2 ) q2( 2 ) ( 2) 11 ( 2) 2 1 ( 2) 21 ( 2) ( 2) 1 2 ( 2) 12 (1) 2 ( 2) ( 2) 1 2 ( 2) 22 ( 2) 2 2 (1) 2 2 (1) 21 (1) 21 ( 2 ) (1) 1 2 (1) 22 (1) 2 (1) 1 (1) 22 (1) ( 2 ) 2 q2 (1) 2 ( 2) 1 ( 2) 11 ( 2) 12 ( 2) 1 ( 2) 1 ( 2) 2 ( 2) 21 ( 2) 22 ( 2) 2 ( 2) 2 20% immunocompromised 80% healthy Divide population into two groups, healthy and immunocompromised, which mix at random. Consider different epidemiological effects of immune compromise: NO EFFECT (0), S, I , I, SI, SI (assume 10-fold changes) Infectiousness can vary via either the rate or duration of transmission. Normal I rate t I duration t t Covariation of epidemiological parameters When susceptibility and infectiousness co-vary, R0 for the heterogeneous population R0 in a healthy population. R0 = 1 in healthy population 1000 R0 in 100 heterogeneous population 10 1 100 10 1 Relative susceptibility of group 2 0.1 0.01 0.01 0.1 1 10 100 Relative infectiousness of group 2 Pathogen invasion, without evolution Heterogeneous susceptibility only Probability of invasion 0.8 0.6 0.4 0.2 0 0 2 4 R0 in healthy population 6 1 Probability of invasion S 0 S 1 S 0 S 0.8 0.6 0.4 0.2 0 0 2 4 6 R0 in heterogeneous population See Becker & Marschner, 1990. Pathogen invasion, without evolution Heterogeneous infectiousness only 1 I 0 I 0.8 0.6 Probability of invasion Probability of invasion 1 0.4 0.2 0 0 2 4 R0 in healthy population 6 0 I 0.8 0.6 I 0.4 0.2 0 0 2 4 6 R0 in heterogeneous population See Lloyd-Smith et al, 2005. Pathogen invasion: co-varying parameters Probability of invasion 0.8 0.6 SI 0.4 0.2 0 0 2 4 R0 in healthy population 6 1 Probability of invasion SI S I 0 1 S, 0 SI I SI 0.8 0.6 0.4 0.2 0 0 2 4 6 R0 in heterogeneous population Solid lines: infectiousness varies in transmission rate Pathogen invasion: co-varying parameters Probability of invasion 0.8 0.6 SI 0.4 0.2 0 0 2 4 R0 in healthy population 6 1 Probability of invasion SI S I 0 1 S, 0 SI I SI 0.8 0.6 0.4 0.2 0 0 2 4 6 R0 in heterogeneous population Dashed lines: infectiousness varies in duration Pathogen invasion: co-varying parameters Prob. of invasion Population with heterogeneous infectiousness, I R0 when cov(inf, susc) = 0 Pathogen evolution: probability of adaptation One-step adaptation Pr(between) Pr(within) R0 1 0 Adapted 1×10-3 1×10-3 w >> b 1×10-6 2×10-3 w << b 2×10-3 1×10-6 10 0 Probability of adaptation Initial w=b 0 -1 10 10 10 10 -2 -3 -4 within = between within >> between within << between -5 10 -6 10 0 0.5 1 R in healthy population 1.5 Pathogen evolution: probability of adaptation Assuming P(within) = P(between) = 1×10-3 -1 10 10 10 10 -2 -3 -4 -5 10 10 Probability of adaptation Probability of adaptation 10 SI S I 0 SI 0 -1 SI 10 10 10 10 10 -6 10 S 0 SI 0 -2 I -3 -4 -5 -6 0 0.5 1 R0 in healthy population 1.5 10 0 0.5 1 1.5 R0 in heterogeneous population Solid lines: infectiousness varies in transmission rate Dashed lines: infectiousness varies in duration Pathogen evolution: probability of adaptation Assuming P(within) = P(between) = 1×10-3 0 Probability of adaptation 10 10 10 -1 -2 -3 10 10 10 -4 -5 10 10 10 -1 SI -2 I -3 10 10 10 -6 10 S 0 SI 0 Probability of adaptation SI S I 0 SI -4 -5 -6 0 0.5 1 R0 in healthy population 1.5 10 0 0.5 1 1.5 R0 in heterogeneous population Solid lines: infectiousness varies in transmission rate Pathogen evolution: probability of adaptation Assuming P(within) = P(between) = 1×10-3 Probability of emergence 10 10 10 -1 -2 -3 10 10 10 10 -4 -5 -6 0 0.5 1 R0 in healthy population 1.5 S 0 SI 0 10 Probability of emergence SI S I 0 SI 0 10 10 -1 SI -2 I -3 10 10 10 10 -4 -5 -6 0 0.5 1 1.5 R0 in heterogeneous population Dashed lines: infectiousness varies in duration Where does adaptation occur? Proportion of evolution within host Assuming P(within) = P(between) = 1×10-3 1 SI 0.8 I 0.6 S, 0 0.4 SI 0.2 0 0 0.2 0.4 0.6 0.8 1 R0 in heterogeneous population Solid lines: infectiousness varies in transmission rate Dashed lines: infectiousness varies in duration Where does adaptation occur? Proportion of evolution within host Assuming P(within) = P(between) = 1×10-3 1 SI 0.8 I 0.6 S, 0 0.4 SI 0.2 0 0 0.2 0.4 0.6 0.8 1 R0 in heterogeneous population Solid lines: infectiousness varies in transmission rate Dashed lines: infectiousness varies in duration Two-step adaptation adaptation Jackpot model R0 in healthy population 1 0 Initial strain 10 10 10 Solid lines: 2-step adaptation 0 Probability of adaptation Probability of adaptation Dashed lines: 1-step adaptation -2 -4 -6 10 Intermediate Adapted strain strain 0 0.5 1 1.5 R0 in healthy population 10 10 10 0 -2 -4 -6 10 0 0.5 1 1.5 R0 in heterogeneous population Two-step adaptation adaptation Jackpot model R0 in healthy population 1 0 Initial strain Intermediate Adapted strain strain Initial strain Intermediate Adapted strain strain Fitness valley model R0 in healthy population 1 0 Two-step adaptation: crossing valleys Pr(between) Pr(within) w=b 1×10-3 1×10-3 w >> b 1×10-6 2×10-3 w << b 2×10-3 1×10-6 -2 Probability of adaptation 10 1 0 Initial Intermediate Adapted strain strain strain within = between within << between within >> between 10 10 R0 I 0 -4 -6 -8 10 10 -10 10 -6 -4 10 10 -2 R0 of intermediate strain 10 0 HIV and acute respiratory infections Studies from Chris Hari-Baragwanath Hospital in Soweto. Bacterial respiratory tract infections (Madhi et al, 2000, Clin Inf Dis): Viral respiratory tract infections (Madhi et al, 2000, J. Ped.): HIV and acute respiratory infections Alagiriswami & Cheeseman, 2001 Evans et al, 1995 Couch et al, 1997 Illustration: HIV prevalence and influenza emergence Assuming: Susceptibility is 8 higher in HIV+ group, and infections last 3 longer. P(within) = 1×10-3 Two-step jackpot adaptation P(between) = 1×10-6 R0 = 2 for adapted strain Probability of emergence 1 20% 10% 10-3 5% 1% 0% 10-6 HIV prevalence 10-9 0 0.5 1 R0 in healthy population 1.5 Summary and future directions Invasion • An immunocompromised group can provide a toe-hold for emergence of an unadapted pathogen. • Positive covariance between susceptibility and infectiousness can greatly amplify this effect. Adaptation • Within-host evolution is crucial at low R0, and when pathogen must cross fitness valleys to adapt. • Prolonged duration of infection has greater influence on emergence than faster rate of transmission. Next steps • Link epi and evolution: incorporate effect of pathogen load? • Data!! On susceptibility and infectiousness as a function of immune status, and on pathogen fitness landscapes. • HIV: more data needed at individual and population levels Acknowledgements Ideas and insights Bryan Grenfell, Mary Poss, Peter Hudson, and many other colleagues at CIDD (Penn State) Wayne Getz (UC Berkeley) Brian Williams (WHO) Sebastian Schreiber (UC Davis) Funding CIDD Fellowship for research DIMACS and NSF for travel Additional material Pathogen evolution – approximate calculations Can distinguish between mechanisms of evolution by considering the total ‘opportunity’ for each to work. Total infectious duration = L Total number of transmission events = B Andre & Day (2005) showed, for a homogeneous population, that P(one-step adaptation) ~ L + u B This argument can be generalized to the multi-group setting, using the theory of absorbing Markov processes. In addition to the approximate P(adaptation), can derive the approximate proportion of emergence events due to within-host vs between-host adaptation Influence of covariation when overall R0 is fixed I Prob. of emergence 1 0.8 0.6 0.6 0.4 0.4 0.2 0.2 0 5 4 R0 in 0 3 heterogeneous population 100 2 10 1 1 0 0.01 0.1 Relative susceptibility of group 2 Influence of covariation when overall R0 is fixed I Overall R0 = 3 P(emergence) P(em if index in group 1) P(em if index in group 2) P(index in group 1) 1 0.9 0.8 Probability 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 -2 10 -1 10 10 0 10 1 Relative susceptibility of group 2 2 10 Influence of covariation when overall R0 is fixed Overall R0 = 3 S P(emergence) P(em if index in group 1) P(em if index in group 2) P(index in group 1) 0.8 0.7 Probability 0.6 0.5 0.4 0.3 0.2 0.1 0 -2 10 -1 10 10 0 10 1 Relative infectiousness of group 2 2 10 Previous work on modelling emergence Antia et al, 2003 (between-host evolution, homogeneous population) If introduced strain has R0 < 1, ultimate emergence is more likely as R0 approaches 1. Andre & Day, 2005 (within- and between-host, homogeneous pop.) Duration of infection can be as important as R0. Yates et al, 2006 (between-host only, heterogeneous population without covariation between parameters) Host heterogeneity in susceptibility or infectiousness alone has little effect on emergence. Present goal: analyze disease emergence in a population with heterogeneous immunocompetence so that parameters may co-vary, with both within- and between-host evolution. • But CD4 count isn’t the whole story… HIV’s impact on invasive bacterial infection is thought to be mediated by mononuclear innate immune cells (macrophages, dendritic cells, etc) • Results are indicating that HAART (and resulting elevated CD4 counts) do not reduce risk of bacterial infections. (Noursadeghi et al, Lancet Inf Dis 2006)